Patents by Inventor Enric Espuna Maso

Enric Espuna Maso has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8350018
    Abstract: The present invention relates to Haemophilus parasuis polynucleotides produced by recombinant technology. It also relates to polypeptides that are expressed by said polynucleotides and also to a vaccine against H. parasuis that comprises said polypeptides. In another aspect, the invention also relates to the use of polynucleotides to determine if a strain of H. parasuis is virulent or avirulent.
    Type: Grant
    Filed: September 15, 2006
    Date of Patent: January 8, 2013
    Assignee: Fundacio Centre de Recerca en Sanitat Animal
    Inventors: Albert Bensaid, Sonia Pina Pedrero, Raquel Rivas Adan, Simone Oliveira, Enric Espuña Maso, Carmen Herrero Molina
  • Publication number: 20100285070
    Abstract: The present invention relates to Haemophilus parasuis polynucleotides produced by recombinant technology. It also relates to polypeptides that are expressed by said polynucleotides and also to a vaccine against H. parasuis that comprises said polypeptides. In another aspect, the invention also relates to the use of polynucleotides to determine if a strain of H. parasuis is virulent or avirulent.
    Type: Application
    Filed: September 15, 2006
    Publication date: November 11, 2010
    Applicant: LABORATORIOS HIPRA, S.A.
    Inventors: Albert Bensaid, Sonia Pina Pedrero, Raquel Rivas Adan, Simone Oliveira, Enric Espuña Maso, Carmen Herrero Molina
  • Patent number: 7722882
    Abstract: The present invention provides a method for obtaining an immunogenic, non-haemolytic strain of Actinobacillus pleuropneumoniae which is modified, at least in a segment of the apxIA gene and optionally in a segment of the apxIIA gene that encodes a transmembrane domain of the Apx haemolytic and cytolytic exotoxins. It comprises also the strains, and the attenuated live vaccine porcine pleuorpneumonia obtained therewith.
    Type: Grant
    Filed: November 17, 2003
    Date of Patent: May 25, 2010
    Assignee: Laboratorios Hipra, S.A.
    Inventors: Jaume Piñol Ribas, Sergi Bru Virgili, Enric Espuña Maso, Enrique Querol Murillo
  • Publication number: 20060051371
    Abstract: The present invention provides a method for obtaining an immunogenic, non-haemolytic strain of Actinobacillus pleuropneumoniae which is modified, at least in a segment of the apxIA gene and optionally in a segment of the apxIIA gene that encodes a transmembrane domain of the Apx haemolytic and cytolytic exotoxins. It comprises also the strains, and the attenuated live vaccine porcine pleuorpneumonia obtained therewith.
    Type: Application
    Filed: November 17, 2003
    Publication date: March 9, 2006
    Inventors: Jaume Ribas, Sergi Bru Virgili, Enric Espuna Maso, Enrique Querol Murillo
  • Patent number: 6001370
    Abstract: A new attenuated strain (CNCM Institut Pasteur I-1642) of the virus causing the swine disease known as porcine reproductive and respiratory syndrome (PRRS) is described, along with an attenuation and replication procedure of the same by using a new clone obtained from MA-104 monkey kidney cells (CNCM Institut Pasteur I-1643). Because of the innocuousness on swine and the high immunogenic activity, the said new attenuated strain allows the obtaining of vaccines and diagnostic kits which make possible both the early diagnosis of PRRS and an efficient preventive treatment of such disease.
    Type: Grant
    Filed: November 24, 1997
    Date of Patent: December 14, 1999
    Assignee: Laboratorios Hippra, S.A.
    Inventors: Reina Alemany Burch, Enric Espuna Maso, Pere Riera Pujadas, Narcis Saubi Roca